Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Roche Holdings Ltd ADR (RHHBY)

Roche Holdings Ltd ADR (RHHBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Roche Gets Approval for Vabysmo PFS in EU for Three Retinal Diseases
Roche Gets Approval for Vabysmo PFS in EU for Three Retinal Diseases Zacks Investment Research - Mon Dec 16, 1:44PM CST

Roche RHHBY announced that the European Medicines Agency has approved a prefilled syringe (PFS) of the ophthalmology drug Vabysmo (faricimab).The regulatory body approved Vabysmo PFS for use in the treatment...

GILD : 90.69 (-2.27%)
REGN : 714.62 (-3.43%)
RHHBY : 34.9100 (-2.59%)
BMY : 56.84 (-1.41%)
Regeneron Down 15.5% Year to Date: How to Play the Stock?
Regeneron Down 15.5% Year to Date: How to Play the Stock? Zacks Investment Research - Fri Dec 13, 9:12AM CST

Shares of Regeneron Pharmaceuticals, Inc. REGN have dropped 15.5% in the year so far compared with the industry’s decline of 6.3%.The stock has underperformed the sector and the S&P 500 Index during...

BAYRY : 4.9200 (-2.19%)
REGN : 714.62 (-3.43%)
RHHBY : 34.9100 (-2.59%)
SNY : 47.01 (-3.94%)
Healthcare Executives Embrace Generative AI to Boost Patient Outcomes Newswire.ca - Thu Dec 12, 10:26AM CST

/CNW/ -- USA News Group News Commentary – The healthcare industry is in the midst of a significant shift, driven by advancements in artificial intelligence...

NVDA : 128.91 (-1.14%)
AVAI : 0.5751 (-2.53%)
RHHBY : 34.9100 (-2.59%)
TEM : 34.29 (-11.96%)
AMZN : 220.52 (-4.60%)
AI Healthcare Innovations: How They're Shaping the Future for Patients and Investors Newswire.ca - Thu Dec 12, 10:23AM CST

/CNW/ -- USA News Group News Commentary – The potential for artificial intelligence (AI) in healthcare is exploding, with economists now predicting AI could...

AIDX.TO : 2.10 (-4.11%)
HWAIF : 1.4600 (-4.98%)
AVAI : 0.5751 (-2.53%)
TDOC : 9.46 (-6.06%)
WELL.TO : 7.00 (-1.27%)
RHHBY : 34.9100 (-2.59%)
BFLY : 3.12 (-11.36%)
Industry Survey Reveals Overwhelming Support for AI-Powered Healthcare BayStreet.ca - Thu Dec 12, 9:44AM CST

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – The healthcare sector is undergoing a profound transformation, propelled by the rapid evolution of artificial...

TWST : 44.61 (-7.83%)
AVAI : 0.5751 (-2.53%)
ABSI : 3.04 (-8.71%)
RXRX : 6.22 (-12.64%)
MDAI : 1.7800 (-8.72%)
RHHBY : 34.9100 (-2.59%)
Pharma Stock Roundup: LLY's Zepbound Success, FDA Updates for MRK, JNJ
Pharma Stock Roundup: LLY's Zepbound Success, FDA Updates for MRK, JNJ Zacks Investment Research - Fri Dec 6, 8:18AM CST

This week, Eli Lilly’s LLY popular obesity drug, Zepbound showed better weight loss than Novo Nordisk’s Wegovy in a head-to-head study. The FDA granted Breakthrough Therapy designation to Merck’s...

AZN : 64.64 (-3.78%)
JNJ : 144.75 (-1.13%)
MRK : 98.34 (-1.72%)
LLY : 764.71 (-1.79%)
RHHBY : 34.9100 (-2.59%)
The Intersection of AI, Medicine, and Stocks: A New Era of Opportunities FinancialNewsMedia - Thu Dec 5, 7:15AM CST

EQNX::TICKER_START (OTCQB:AVAI),(OTCQX:RHHBY),(NASDAQ:AMZN),(NASDAQ:MDAI),(NYSE:MDT) EQNX::TICKER_END

AVAI : 0.5751 (-2.53%)
MDAI : 1.7800 (-8.72%)
RHHBY : 34.9100 (-2.59%)
MDT : 80.03 (-1.65%)
AMZN : 220.52 (-4.60%)
The Future of Medicine: How AI Is Transforming Healthcare and Stock Markets BayStreet.ca - Wed Dec 4, 8:59AM CST

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – Artificial intelligence (AI) is rapidly reshaping the healthcare landscape, with experts suggesting...

AVAI : 0.5751 (-2.53%)
SYK : 359.17 (-3.14%)
RXRX : 6.22 (-12.64%)
RHHBY : 34.9100 (-2.59%)
TEM : 34.29 (-11.96%)
The Intersection of AI, Medicine, and Stocks: A New Era of Opportunities Issued on behalf of Avant Technologies Inc. Newswire.ca - Wed Dec 4, 8:15AM CST

/CNW/ -- USA News Group News Commentary – Artificial intelligence (AI) is revolutionizing healthcare, offering solutions that could dramatically reduce...

AVAI : 0.5751 (-2.53%)
GEHC : 77.09 (-2.73%)
MDAI : 1.7800 (-8.72%)
MDT : 80.03 (-1.65%)
RHHBY : 34.9100 (-2.59%)
AMZN : 220.52 (-4.60%)
Artificial Intelligence (AI) Redefining Medical Diagnostics Industry That’s Expected to be a $7.2 Billion Market by 2029 FinancialNewsMedia - Wed Dec 4, 7:45AM CST

EQNX::TICKER_START (OTCQB:AVAI),(OTCQX:RHHBY),(NASDAQ:RXRX),(NASDAQ:TEM),(NASDAQ:ISRG) EQNX::TICKER_END

AVAI : 0.5751 (-2.53%)
RXRX : 6.22 (-12.64%)
RHHBY : 34.9100 (-2.59%)
TEM : 34.29 (-11.96%)
ISRG : 526.47 (-3.43%)

Barchart Exclusives

2 Dividend Stocks Analysts Love for Fat Yields in 2025 Barchart - Wed Dec 18, 6:30PM CST
These companies have high yields and have strong business models that position them to maintain and potentially increase their dividend payments in 2025. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot